Skip to content

Decoy Therapeutics Inc. (DCOY) Insider Trading -- Recent Executive & Director Transactions

10 insiders reported 10 Form 4 transactions for Decoy Therapeutics Inc. (DCOY) over the past 18 months (most recent 2026-09-02). Recent activity: Rosenblum Mark J (Chief Financial Officer) Buy 9,682 shares, Marschel Peter Klaus (Chief Business Officer) Buy 3,900 shares, HANISH ARNOLD C (Director) Buy 3,000 shares, McVicar William K. (Director) Buy 3,000 shares, Lieber Jonathan I (Director) Buy 2,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-02Rosenblum Mark JChief Financial OfficerBuy9,682$0
2026-09-02Marschel Peter KlausChief Business OfficerBuy3,900$0
2026-09-02HANISH ARNOLD CDirectorBuy3,000$0
2026-09-02McVicar William K.DirectorBuy3,000$0
2026-09-02Lieber Jonathan IDirectorBuy2,000$0
2026-09-02Burleson TessDirectorBuy2,000$0
2026-09-02Hibner Barbara LouiseChief Scientific OfficerBuy4,216$0
2026-09-02PIERCE FREDERICK IIChief Executive OfficerBuy33,455$0
2026-09-02Gauthier Patricia G.DirectorBuy2,000$0
2026-09-02Lammers PaulDirectorBuy2,000$0

Source: SEC Form 4 filings · as of 2026-09-02